Teladoc Health (NYSE: TDOC) insider files to sell 3,897 recently vested shares

Rhea-AI Filing Summary

Teladoc Health insider plans sale of recently vested shares. A holder of Teladoc Health common stock filed a notice of proposed sale covering 3,897 shares to be sold through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of 12/02/2025. These shares were acquired on 12/01/2025 through restricted stock vesting from the issuer as compensation. The filing notes that 177,473,405 shares of Teladoc Health common stock were outstanding. It also reports that the same seller disposed of 3,998 common shares on 09/02/2025 for gross proceeds of $30,326.03. The seller represents that they are not aware of undisclosed material adverse information about the company.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3897	29181.91	177473405	12/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/01/2025	Restricted Stock Vesting	Issuer			3897	12/01/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Carlos Nueno Plana 155 E 44th Street Suite 1700 New York NY 10017	Common	09/02/2025	3998	30326.03

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Teladoc Health (TDOC) Form 144 filing disclose?

The notice discloses a planned sale of 3,897 shares of Teladoc Health common stock by an existing holder. The shares are expected to be sold on or about 12/02/2025 through Fidelity Brokerage Services LLC on the NYSE.

How were the Teladoc Health (TDOC) shares in this Form 144 acquired?

The 3,897 common shares to be sold were acquired on 12/01/2025 via restricted stock vesting from the issuer, with the nature of payment described as compensation.

How many Teladoc Health (TDOC) shares are outstanding according to this filing?

The filing states that there were 177,473,405 shares of Teladoc Health common stock outstanding at the time referenced in the notice.

Does the Teladoc Health (TDOC) Form 144 mention prior share sales?

Yes. It reports that the same seller previously sold 3,998 common shares on 09/02/2025, generating gross proceeds of $30,326.03.

What assurances does the seller give in the Teladoc Health (TDOC) Form 144?

The seller represents that they do not know of any material adverse information regarding the current or prospective operations of Teladoc Health that has not been publicly disclosed.

Which broker is handling the planned Teladoc Health (TDOC) share sale?

The planned sale of 3,897 common shares is listed as being handled by Fidelity Brokerage Services LLC, located in Smithfield, Rhode Island.